Chronic cerebral hypoperfusion accelerates cognitive dysfunction and microvascular impairment in the MPTP mouse model of Parkinson’s disease
Objective: To evaluate cerebral hypoperfusion on cognitive dysfunction and related microvascular impairment in the MPTP mouse model. Background: Vascular pathology and Parkinson's disease (PD) pathology…Frequency and characteristics of diplopia in non-demented patients with Parkinson’s disease
Objective: To assess the frequency of diplopia and its relation to motor and non-motor symptoms in a cross sectional sample of non-demented patients with idiopathic…Magnetic resonance characteristic of Parkinson’s disease based on the presence of cognitive impairment
Objective: To study the performance of MRI in patients with Parkinson's disease, depending on the stage of the disease. Background: Steadily progressive chronic neurodegenerative disease…Assessment of cognitive-motor interference during an upper extremity motor task in Parkinson’s disease
Objective: To assess cognitive-motor interference (CMI) and task prioritization during simultaneous performance of a cognitive task and an upper extremity motor task in Parkinson's disease…Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia
Objective: Aim of this study was to identify the degree of cognitive dysfunction in patients with subcortical Parkinsonian dementia, during the neuroprotective therapy. Background: Parkinson's…The effect of dopamine on global versus specific inhibitory control in Parkinson’s disease
Objective: To evaluate the effect of dopaminergic medication on inhibitory control using a novel go/no-go task in Parkinson's disease (PD). Global cognition and motor examination…Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination
Objective: To evaluate the correlation between cognitive and functional performance of Parkinsonian with normal Mini-Mental State Examination (MMSE), and demographic variables, motor impairment, neuropsychiatric disorders…Cytokines in CSF and plasma as potential biomarkers for PD cognitive impairment
Objective: To assess CSF and plasmatic levels of cytokines as potential biomarkers of PD and PD mild cognitive impairment (PD-MCI). Background: Neuroinflammation may play a…Comparison of the utility of three cognitive scales for MDS Level-I diagnosis of mild cognitive impairment in Parkinson’s disease: MoCA, PD-CRS and ACE-III
Objective: To compare the utility for detecting Mild Cognitive Impairment in Parkinson's disease (PD-MCI) of three abbreviated global scales: the Montreal Cognitive Assessment (MoCA), the…Cognitive development in individuals with mild Parkinsonian signs
Objective: With this study we aimed to prospectively evaluate the development of cognitive performance in individuals with persistent Mild Parkinsonian Signs (MPS) compared to neurologically…